首页> 外国专利> PYRROLOTRIAZINONE AND IMIDASOTRIAZINONE DERIVATIVES AS OBIQUITIN-SPECIFIC PROTEASE 7 CUSP? ) INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER USP7 MEDIATED DISEASES

PYRROLOTRIAZINONE AND IMIDASOTRIAZINONE DERIVATIVES AS OBIQUITIN-SPECIFIC PROTEASE 7 CUSP? ) INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER USP7 MEDIATED DISEASES

机译:吡咯并三嗪酮和咪唑并三嗪酮衍生物是奥比喹汀特异蛋白酶7 SP? )治疗癌症和其他USP7介导疾病的抑制剂

摘要

The invention relates to pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one and imidazo[5,1-f][1,2,4]triazin-4(3H)-one derivatives as inhibitors of the ubiquitin-specific protease 7 (USP7) useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula (I) where Rl, R2, R3, R4, Rs, Rs', R6, Xl, X2, m, and n are described herein.
机译:本发明涉及吡咯并[2,1-f] [1,2,4]三嗪-4(3H)-一和咪唑并[5,1-f] [1,2,4]三嗪-4(3H)-具有泛素特异性蛋白酶7(USP7)抑制剂的一种衍生物,可用于治疗癌症,神经退行性疾病,免疫疾病,炎性疾病,心血管疾病,局部缺血性疾病,病毒感染和疾病以及细菌感染和疾病,具有以下化学式(I)其中R l ,R 2 ,R 3 ,R 4 ,R s < / Sub>,R s',R 6 ,X l ,X 2 ,m和n为本文所述。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号